Pre-clinical studies using OxyVita hemoglobin, a zero-linked polymeric hemoglobin: A review

Journal of Artificial Organs

Volumn 13, Issue 4, 2010, Pages 183-188

  Harrington, John P ^a   Wollocko, Hanna ^a  

^a Oxyvita Inc   (United States)

Author keywords

Acellular hemoglobin; Blood substitutes; Hemoglobin based oxygen carrier; Zero linked polymeric hemoglobin

Indexed keywords

DIASPIRIN CROSSLINKED HEMOGLOBIN; HEMATOLOGIC AGENT; HEMOGLOBIN BASED OXYGEN CARRIER; HEMOGLOBIN GLUTAMER 200; HEMOGLOBIN RAFFIMER; HEMOSPAN; OXYGEN; OXYVITA HB; POLYMER; POLYMERIZED HEMOGLOBIN; RECOMBINANT HEMOGLOBIN; UNCLASSIFIED DRUG;

BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD FLOW; BRAIN CIRCULATION; BRAIN ISCHEMIA; DRUG BINDING; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; HUMAN; IN VIVO STUDY; INJURY; LIQUID; MOLECULAR WEIGHT; NONHUMAN; PHYSICAL CHEMISTRY; POLYMERIZATION; POWDER; PRESSOR RESPONSE; PRIORITY JOURNAL; RESUSCITATION; REVIEW; VASOCONSTRICTION;

ANIMALS; BLOOD PRESSURE; BLOOD SUBSTITUTES; DRUG EVALUATION, PRECLINICAL; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; HEMOGLOBINS; NITRIC OXIDE; OXYGEN; POLYMERIZATION;

EID: 78650926080     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10047-010-0528-6     Document Type: Review

References (28)

1. T Estep E Bucci M Farmer G Greenberg JP Harrington HW Kim H Klein P Mitchell G Nemo K Olsen A Palmer R Valeri R Winslow 2008 Basic science focus on blood substitutes: a summary of the NHLBI division of blood diseases and resources working group workshop Transfusion 48 776 782 10.1111/j.1537-2995. 2007.01604.x 18194373 (Pubitemid 351430350)
2. PW Buchler AI Alayash 2008 All hemoglobin-based oxygen carriers are not created equally Biochim Biophys Acta 1784 1378 1381
3. RE Hirsch JP Harrington 2000 Blood substitutes: an overview and perspective Einstein Q J Biol Med 17 113 123 1:CAS:528:DC%2BD3MXitV2rtrY%3D
4. Razynska A, Bucci E. Zero-link polymerization: a new class of polymeric hemoglobins. In: Tsuchida E, editor. Blood substitutes-present and future perspectives. Amsterdam: Elsevier; 1998. p. 265-79.
5. Harrington JP, Wollocko J, Kostecki E, Wollocko H. Physicochemical characteristics of OxyVita Hb, a zero-linked polymer: liquid and powder preparations. Artif Cells Blood Substit Biotechnol. 2010;38 (in press).
6. B Urbaitis A Razynska Q Corteza C Fronticelli E Bucci 1991 Intravascular retention and renal handling of purified natural and intramolecularly crosslinked hemoglobins J Lab Clin Med 117 115 121 1:CAS:528:DyaK3MXhsV2qu70%3D 1993852
7. SR Snyder EV Welty RY Walder LA Williams JA Walder 1987 HbXL99 alpha: a hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substitute Proc Natl Acad Sci USA 84 7280 7284 1:CAS:528: DyaL1cXhtFajsg%3D%3D 10.1073/pnas.84.20.7280 3478694
8. F D'Agnillo AI Alayash 2000 Site-specific modifications and toxicity of blood substitutes. The case of diaspirin cross-linked hemoglobin Adv Drug Deliv Res 40 199 212 10.1016/S0169-409X(99)00050-2 (Pubitemid 30068678)
9. JS Olsen EW Foley C Rogge AL Tsai MP Doyle DD Lemon 2004 NO scavenging and the hypertensive effect of hemoglobin-based oxygen carriers Free Radic Biol Med 36 685 697 10.1016/j.freeradbiomed.2003.11.030 (Pubitemid 38264413)
10. 6-HbA is non-hypertensive Artif Cells Blood Substit Immobil Biotechnol 33 239 255 1:CAS:528: DC%2BD2MXhtVWlt73L 10.1081/BIO-200066365 16152690 (Pubitemid 41190931)
11. AI Alayash F D'Agnillo PW Beuhler 2007 First generation blood substitutes: what have we learned? Biochemical and physiological perspectives Expert Opin Biol Ther 7 665 675 1:CAS:528:DC%2BD2sXkvVCis7k%3D 10.1517/14712598.7.5.665 17477804 (Pubitemid 46707189)
12. RM Winslow 2008 Cell-free oxygen carriers: scientific foundations, clinical development, and new directions Biochim Biophys Acta 1784 1382 1386 1:CAS:528:DC%2BD1cXhtFCkurfP 18555029
13. B Matheson HE Kwansa E Bucci A Rebel RC Koehler 2002 Vascular response to infusions of a nonextravasating hemoglobin polymer J Appl Physiol 93 1479 1486 1:CAS:528:DC%2BD38XotFOqtbw%3D 12235050
14. 2 Am J Physiol Heart Circ Physiol 285 1600 1608
15. T Mito M Nemoto H Kwansa K Sampei M Habeeh SJ Murphy E Bucci RC Koehler 2009 Decreased damage from transient focal cerebral ischemia by transfusion of zero-linked hemoglobin polymers in mouse Stroke 40 278 284 1:CAS:528: DC%2BD1cXhsFWisr3L 10.1161/STROKEAHA.108.526731 18988905
16. PS Reynolds RW Barbee MD Skaflen KR Ward 2007 Low-volume resuscitation cocktail extends survival after severe hemorrhagic shock Shock 28 45 52 1:CAS:528:DC%2BD2sXotV2gtL8%3D 10.1097/shk.0b013e31802eb779 17483745 (Pubitemid 46956462)
17. JS Jahr DL Weeks P Desai JC Lim W Butch R Gunther B Driessen 2008 Does OxyVita, a new-generation hemoglobin-based-oxygen carrier, or Oxyglobin acutely interfere with coagulation compared with normal saline or 6% Hetastarch? A ex vivo thromboelastography study J Cardiothorac Vasc Anesth 22 34 39 10.1053/j.jvca.2007.02.016 18249328 (Pubitemid 351179382)
18. M Moallempour JS Jahr JC Lim D Weeks AW Butch B Dreissen 2009 Methemoglobin effects on coagulation: a dose-response study with HBOC-200 (OxyGlobin) in a thromboelastogram model J Cardiothorac Vasc Anesth 23 41 47 1:CAS:528:DC%2BD1MXnslWmtrg%3D 10.1053/j.jvca.2008.06.006 18834828
19. K Sampei JA Ulatowski Y Asano H Kwansa E Bucci RC Koehler 2005 Role on nitric oxide scavenging in vascular response to cell-free hemoglobin transfusion Am J Physiol Heart Circ Physiol 289 H1191 H1201 1:CAS:528:DC%2BD2MXhtVWktrzL 10.1152/ajpheart.00251.2005 15894576 (Pubitemid 41208963)
20. B Rippe B Haraldsson 1994 Transport of macromolecules across microvascular walls: the two pore theory Physiol Rev 74 163 219 1:CAS:528:DyaK2cXhvVOktrg%3D 8295933
21. Scandinavian Stroke Study Group 1988 Multicenter trial of hemodilution in acute ischemic stroke Stroke 19 464 471
22. The Hemodilution in Stroke Study Group. Hypervolemic hemodilution treatment of acute stroke. Results of a randomized multicenter trial using pentastarch. Stroke. 1989;20:317-23.
23. JA Klaus KK Kibler A Abuchhowski RC Kohler 2010 Early treatment of transient focal cerebral ischemia with bovine PEGylated carboxy hemoglobin transfusion Artif Cells Blood Substit Biotechnol 38 223 229 1:CAS:528: DC%2BC3cXhtFChsLjJ 10.3109/10731199.2010.488635
24. RG Strauss BJ Pennell DC Stump 2002 A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch Transfusion 42 27 36 1:CAS:528:DC%2BD38Xit1ehtL4%3D 10.1046/j.1537-2995.2002.00003.x 11896309
25. C Huraux A Ankri D Eyraud 2001 Hemostatic changes in patients receiving hydroxyethyl starch: the influence of ABO blood group Anesth Analg 92 1396 1401 1:CAS:528:DC%2BD3MXksVyht70%3D 10.1097/00000539-200106000-00007 11375811
26. D Royston S von Kier 2001 Reduced haemostatic factor transfusion using heparinase-modified thromboelastography during cardiopulmonary bypass Br J Anaesth 86 575 578 1:STN:280:DC%2BD3MrislKrtA%3D%3D 10.1093/bja/86.4.575 11573637 (Pubitemid 32266324)
27. DW Essex M Li 2006 Redox modification of platelet glycoproteins Curr Drug Targets 7 1233 1241 1:CAS:528:DC%2BD28XhtVCjsbbO 10.2174/138945006778559193 17073584 (Pubitemid 44509686)
28. JP Harrington K Orlig SL Zito J Wollocko H Wollocko 2010 Structural and redox behavior of OxyVita Hb, a zero-linked polymeric hemoglobin: comparison with natural acellular polymeric hemoglobins Artif Cells Blood Substit Biotechnol 38 64 68 1:CAS:528:DC%2BC3cXjtFKgtbw%3D 10.3109/10731191003634562